Popular search terms:
Search Results
60 results found-
Contact CSL Limited corporate communications team for products and investor relations.
https://www.csl.com/news/newsroom -
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
https://www.csl.com/ -
CSL continues to provide medicines to patients around the world.
https://www.csl.com/news/2020/covid-19-update -
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
https://www.csl.com/news/2020/20201008-csl-finalises-agreement-to-supply-51mil-doses-of-uq-covid19-vaccine -
CSL Behring agrees to acquire novel late-stage gene therapy candidate for Hemophilia B patients from uniQure
https://www.csl.com/news/2020/20201015-2021-csl-centenary-fellowships-announced -
The Alliance’s anti-COVID-19 Hyperimmune Globulin (CoVIg-19) medicine is under evaluation as part of the trial and may become one of the earliest treatments for hospitalized individuals at risk for serious complications of COVID-19
https://www.csl.com/news/2020/20201009-first-patient-enrolled-in-nih-covid19-phase-3-trial -
CSL is working around the world with academia, industry and governments to combat the novel coronavirus COVID-19
https://www.csl.com/news/2020/covid-19-csl-facts -
Forbes Recognizes Global Biotechnology Leader for Fourth Straight Year
https://www.csl.com/news/2020/20201029-csl-named-as-one-of-the-worlds-best-employers